Merus N.V. Common Shares. Replay the stock market charts of MRUS day by day back to 2003. Open long and short positions without spending any money. Merus NV is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics.
